Catalent is Up 22% Amidst Acquisition Rumors: Is the Stock Worth a Buy, Though?
Catalent (CTLT) is all over the headlines this Monday morning as rumors surge of an acquisition. The buyer in question is Danaher (DHR), a company that designs and manufactures diagnostic tools for health, food, and water services. This play is said to be Danaher’s way of competing with Thermo Fisher Scientific. This marriage makes [...]